Nerve ablation for irregular heart rhythm
Part of Heart & circulation clinical trials.
This study tests a procedure called sympathetic ablation, which targets the nerves that contribute to dangerous heart rhythms in people with implanted defibrillators. The goal is to reduce the number of shocks from your device and improve your quality of life.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You must have an implantable defibrillator (ICD) or a CRT-D device in your chest.
- You have had repeated episodes of a fast, dangerous heart rhythm (ventricular tachycardia) that your defibrillator corrected with a shock or pacing.
- Your doctor has determined that a catheter ablation (a procedure to destroy the abnormal heart tissue) is appropriate for you.
- You have not had prior surgery or procedures on the nerves in your neck/chest that control your heart rhythm.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new catheter system (Sphere-9 and Affera) to treat a fast, dangerous heartbeat called ventricular tachycardia (VT) in people with heart scarring. It aims to see if this system is safe and effective at stopping VT, especially if past treatments haven't worked.
This study tests a new way to find the exact spot in the heart that causes rapid heartbeats, so doctors can treat it more precisely with a procedure called catheter ablation.
This trial studies a non-invasive treatment using focused radiation to target the heart tissue causing dangerous heart rhythms. It may be an option for people who have already had a catheter ablation but still get episodes of ventricular tachycardia.
This study tests a new catheter-based treatment for people with certain types of very fast or extra heartbeats that come from the lower chambers of the heart. The catheter uses a special energy to stop the abnormal beats and might help if you have had symptoms despite other treatments.
This trial tests a new catheter-based procedure to treat life-threatening irregular heartbeats (ventricular tachycardia) that keep coming back despite medication. If you've had a heart attack and your implanted defibrillator hasn't fully controlled these arrhythmias, this procedure might help prevent future episodes.
This study compares two catheter-based procedures to treat ventricular tachycardia (VT), a fast, dangerous heart rhythm. It looks to see which approach works better at reducing repeat VT events in people with weakened heart pumping.
Hear when a new Ventricular Tachycardia (VT) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.